{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for betaine in Reference Text / Citation (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 358
(1999)
Source URL:
First approved in 1999
Source:
21 CFR 358
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
Somatyl by Anphar-Rolland
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Betaine sodium aspartate is a medication, containing sodium aspartate (a salt of non-essential amino acid), and amino acid derivative betaine (trimethylglycine). Betaine is structurally related to choline and serves as a methyl donor. The donation of methyl groups by betaine is important to proper liver function, cellular replication, and detoxification reactions. Dietary sources of betaine include fish, beets, and legumes. Betaine sodium aspartate is available as over-the-counter medicine is some European countries under the tradename Somatyl. It is indicated as an adjuvant treatment in digestive failure.
Status:
Possibly Marketed Outside US
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Other
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 356
(2023)
Source URL:
First approved in 2019
Source:
MedicatedShampoo by Shenzhen Wanfeng Hao Electronic Commerce Co., Ltd.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2020)
Source URL:
First approved in 2011
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 356
(2023)
Source URL:
First approved in 2004
Source:
21 CFR 346
Source URL:
Class:
MIXTURE
Status:
First approved in 1999
Source:
Dermal-Soothe by Vetoquinol USA, Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(1998)
Source URL:
First approved in 1985
Source:
NDA021644
Source URL:
Class:
MIXTURE
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
